血清尿酸、蛋白质摄入与血液透析患者死亡率
在2007年1月1日至2011年12月31日期间启动血液透析且有至少一次血清尿酸测量的4298例患者中,分析血清尿酸与全因死亡率的关系。平均血清尿酸为6.6±1.8 mg/dL。低血清尿酸(<5.0 mg/dL)与更高的全因死亡率相关(HR 1.42,95%CI 1.16-1.72),而高血清尿酸(≥8.0 mg/dL)与参考组(>6.0-7.0 mg/dL)相比无显著死亡率风险(HR 0.90,95%CI 0.72-1.13)。低血清尿酸与死亡率的关联受标准化蛋白质分解代谢率(nPCR)显著修饰(交互作用P=0.001),在低nPCR(<0.9 g/kg/天)患者中持续存在(HR 1.73,95%CI 1.42-2.10),在高nPCR(≥0.9 g/kg/天)患者中不存在(HR 0.99,95%CI 0.74-1.33)。
要点
- 血清尿酸可能反映血液透析患者的营养状态。
- 低血清尿酸(<5.0 mg/dL)而非高血清尿酸与血液透析患者全因死亡率升高相关。
- 低nPCR(<0.9 g/kg/天)患者中低血清尿酸与死亡率关联持续存在(HR 1.73,95%CI 1.42-2.10),高nPCR患者中不存在(HR 0.99,95%CI 0.74-1.33)。
核心结论
- 血清尿酸可能是血液透析患者的营养标志物。
- 与一般人群相反,低血清尿酸而非高血清尿酸与血液透析患者更高的全因死亡率相关,尤其在低蛋白质摄入患者中。
- 血清尿酸的营养特征有待进一步研究。
研究设计与样本
- 在2007年1月1日至2011年12月31日期间,识别4298例启动血液透析且有一次或多次血清尿酸测量的患者。
- 根据首次尿酸测量分析生存概率,调整透析龄、病例组合和营养不良-炎症复合体相关变量。
主要发现
- 平均血清尿酸浓度为6.6±1.8 mg/dL。
- 较高的血清尿酸与更好的营养状态和更低的全因死亡率一致相关,无论调整模型如何(趋势P<0.001)。
- 在病例组合调整模型中,最高血清尿酸类别(≥8.0 mg/dL)与参考组(>6.0-7.0 mg/dL)相比无显著死亡率风险(HR 0.90,95%CI 0.72-1.13)。
- 最低血清尿酸类别(<5.0 mg/dL)与更高的死亡率相关(HR 1.42,95%CI 1.16-1.72)。
- 低血清尿酸(<5.0 mg/dL)的死亡率风险在低nPCR(<0.9 g/kg/天)患者中持续存在(HR 1.73,95%CI 1.42-2.10),但在高nPCR(≥0.9 g/kg/天)患者中不存在(HR 0.99,95%CI 0.74-1.33)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The association between serum uric acid (SUA) and mortality has been conflicting among studies using hemodialysis (HD) patients. Given the close link between purine and protein in foods, we hypothesized that normalized protein catabolic rate (nPCR), a dietary protein intake surrogate, modifies the SUA-mortality association in the HD population. METHODS: We identified 4298 patients who initiated HD and had one or more SUA measurement in a contemporary cohort of HD patients over 5 years (1 January 2007-31 December 2011), and examined survival probability according to the first uric acid measurement, adjusting for dialysis vintage, case-mix and malnutrition-inflammation complex-related variables. RESULTS: Mean SUA concentration was 6.6 ± 1.8 mg/dL. There was a consistent association of higher SUA with better nutritional status and lower all-cause mortality irrespective of adjusted models (Ptrend < 0.001). In the case-mix adjusted model, the highest SUA category (≥8.0 mg/dL) compared with the reference group (>6.0-7.0 mg/dL) showed no significant mortality risk [hazard ratio (HR) 0.90, 95% confidence interval (CI) 0.72-1.13], while the lowest category (<5.0 mg/dL) was associated with higher mortality (HR 1.42, 95% CI 1.16-1.72). The hypouricemia-mortality association was significantly modified by nPCR (Pinteraction = 0.001). Mortality risk of low SUA (<5.0 mg/dL) persisted among patients with low nPCR (<0.9 g/kg/day; HR 1.73, 95% CI 1.42-2.10) but not with high nPCR (≥0.9 g/kg/day; HR 0.99, 95% CI 0.74-1.33). CONCLUSIONS: SUA may be a nutritional marker in HD patients. Contrary to the general population, low but not high SUA is associated with higher all-cause mortality in HD patients, especially in those with low protein intake. Nutritional features of SUA warrant additional studies.
引用
- Park C, Obi Y, Streja E, et al. Serum uric acid, protein intake and mortality in hemodialysis patients. Nephrol Dial Transplant. 2017. PMID: 28064158. doi:10.1093/ndt/gfw419
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。